Concepedia

Laura Tsujikawa

LT

16

Publications

823

Citations

14

H-Index

2001

Active since

Affiliations

Resverlogix (Canada)(Current)

Case Western Reserve University

University of California, Irvine

University of Calgary

Laura Tsujikawa is an author at Resverlogix (Canada) specializing in medicine, immunology, and atherosclerosis.

Top concepts

Publications per year

2001–2022

16

Publications

16

RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist

Kevin G. McLure, Emily M. Gesner, Laura Tsujikawa et al. · PLoS ONE · 2013 · 198 citations · Full text

, , +20

Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

Laura Tsujikawa, Li Fu, Shovon Das et al. · Clinical Epigenetics · 2019 · 117 citations · Full text

RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease

Dean Gilham, Sylwia Wasiak, Laura Tsujikawa et al. · Atherosclerosis · 2016 · 112 citations · Full text

, , +12

Different Roles for Basic and Aromatic Amino Acids in Conserved Region 2 of Escherichia coli ς70 in the Nucleation and Maintenance of the Single-stranded DNA Bubble in Open RNA Polymerase-Promoter Complexes

Mark Tomsic, Laura Tsujikawa, Gianina Panaghie et al. · Journal of Biological Chemistry · 2001 · 69 citations · Full text

Apabetalone downregulates factors and pathways associated with vascular calcification

Dean Gilham, Laura Tsujikawa, Christopher D. Sarsons et al. · Atherosclerosis · 2018 · 65 citations · Full text

Rows per page

1–5 of 16